[Demonstration of a depressive component in the central effects of nikethamide].
D000818:Animals; D001831:Body Temperature / Q000187:drug effects*; D002490:Central Nervous System / Q000187:drug effects*; D002697:Chloral Hydrate / Q000494:pharmacology; D004357:Drug Synergism; D005260:Female; D006591:Hexobarbital / Q000494:pharmacology; D006993:Hypnotics and Sedatives / Q000378:metabolism / Q000494:pharmacology*; D008297:Male; D051379:Mice; D009536:Niacinamide; D009552:Nikethamide / Q000494:pharmacology*; D010424:Pentobarbital / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology; D012890:Sleep / Q000187:drug effects*; D013997:Time Factors; D014851:Wakefulness / Q000187:drug effects
D006993:Hypnotics and Sedatives; D009536:Niacinamide; D009552:Nikethamide; D002697:Chloral Hydrate; D011335:Proadifen; D006591:Hexobarbital; D010424:Pentobarbital
Mise en évidence d'une composante dépressive dans les effets centraux du nicéthamide.